Elizabeth Donegan, MD

Professor Emeritus

Publications: 
Moncada J, Donegan E, Schachter J. Evaluation of CDC-recommended approaches for confirmatory testing of positive Neisseria gonorrhoeae nucleic acid amplification test results. J Clin Microbiol. 2008 May; 46(5):1614-9.
Donegan EA, Wirawan DN, Muliawan P, Schachter J, Moncada J, Parekh M, Knapp JS. Fluoroquinolone-resistant Neisseria gonorrhoeae in Bali, Indonesia: 2004. Sex Transm Dis. 2006 Oct; 33(10):625-9.
Pisani E, Girault P, Gultom M, Sukartini N, Kumalawati J, Jazan S, Donegan E. HIV, syphilis infection, and sexual practices among transgenders, male sex workers, and other men who have sex with men in Jakarta, Indonesia. Sex Transm Infect. 2004 Dec; 80(6):536-40.
Donegan E, Moncada J, Chernesky M, Schachter J. Sexually transmitted infection/HIV laboratory testing in resource-limited countries: steps to improve use effective testing and to ensure diagnostic capacity. Sex Transm Dis. 2003 Dec; 30(12):905-8.
Foley B, Donegan E, Silitonga N, Wignall FS, Busch MP, Delwart EL. Importation of multiple HIV type 1 strains into West Papua, Indonesia (Irian Jaya). AIDS Res Hum Retroviruses. 2001 Nov 20; 17(17):1655-9.
Keltner JR, Donegan E, Hynson JM, Shapiro WA. Acute renal failure after radiofrequency liver ablation of metastatic carcinoid tumor. Anesth Analg. 2001 Sep; 93(3):587-9.
Leong SP, Donegan E, Heffernon W, Dean S, Katz JA. Adverse reactions to isosulfan blue during selective sentinel lymph node dissection in melanoma. Ann Surg Oncol. 2000 Jun; 7(5):361-6.
Korn AP, Hessol NA, Padian NS, Bolan GA, Donegan E, Landers DV, Schachter J. Risk factors for plasma cell endometritis among women with cervical Neisseria gonorrhoeae, cervical Chlamydia trachomatis, or bacterial vaginosis. Am J Obstet Gynecol. 1998 May; 178(5):987-90.
Operskalski EA, Stram DO, Busch MP, Huang W, Harris M, Dietrich SL, Schiff ER, Donegan E, Mosley JW. Role of viral load in heterosexual transmission of human immunodeficiency virus type 1 by blood transfusion recipients. Transfusion Safety Study Group. Am J Epidemiol. 1997 Oct 15; 146(8):655-61.
Hilton JF, Donegan E, Katz MH, Canchola AJ, Fusaro RE, Greenspan D, Greenspan JS. Development of oral lesions in human immunodeficiency virus-infected transfusion recipients and hemophiliacs. Am J Epidemiol. 1997 Jan 15; 145(2):164-74.
Essary LR, Kinard SJ, Butcher A, Wang H, Laycock KA, Donegan E, McCreedy B, Connell S, Batchelor J, Harris J, Spadoro J, Pepose JS. Screening potential corneal donors for HIV-1 by polymerase chain reaction and a colorimetric microwell hybridization assay. Am J Ophthalmol. 1996 Oct; 122(4):526-34.
Donegan E, Wright TL, Roberts J, Ascher NL, Lake JR, Neuwald P, Wilber J, Quan S, Kuramoto IK, Dinello RK. Detection of hepatitis C after liver transplantation. Four serologic tests compared. Am J Clin Pathol. 1995 Dec; 104(6):673-9.
Korn AP, Hessol N, Padian N, Bolan G, Muzsnai D, Donegan E, Jonte J, Schachter J, Landers DV. Commonly used diagnostic criteria for pelvic inflammatory disease have poor sensitivity for plasma cell endometritis. Sex Transm Dis. 1995 Nov-Dec; 22(6):335-41.
Operskalski EA, Stram DO, Lee H, Zhou Y, Donegan E, Busch MP, Stevens CE, Schiff ER, Dietrich SL, Mosley JW. Human immunodeficiency virus type 1 infection: relationship of risk group and age to rate of progression to AIDS. Transfusion Safety Study Group. J Infect Dis. 1995 Sep; 172(3):648-55.
Lee TH, Donegan E, Slichter S, Busch MP. Transient increase in circulating donor leukocytes after allogeneic transfusions in immunocompetent recipients compatible with donor cell proliferation. Blood. 1995 Mar 1; 85(5):1207-14.
Goodarzi MO, Lee TH, Pallavicini MG, Donegan EA, Busch MP. Unusual kinetics of white cell clearance in transfused mice. Transfusion. 1995 Feb; 35(2):145-9.
Gjerset GF, Pike MC, Mosley JW, Hassett J, Fletcher MA, Donegan E, Parker JW, Counts RB, Zhou Y, Kasper CK. Effect of low- and intermediate-purity clotting factor therapy on progression of human immunodeficiency virus infection in congenital clotting disorders. Transfusion Safety Study Group. Blood. 1994 Sep 1; 84(5):1666-71.
O'Brien TR, Busch MP, Donegan E, Ward JW, Wong L, Samson SM, Perkins HA, Altman R, Stoneburner RL, Holmberg SD. Heterosexual transmission of human immunodeficiency virus type 1 from transfusion recipients to their sex partners. J Acquir Immune Defic Syndr. 1994 Jul; 7(7):705-10.
Donegan E, Lee H, Operskalski EA, Shaw GM, Kleinman SH, Busch MP, Stevens CE, Schiff ER, Nowicki MJ, Hollingsworth CG. Transfusion transmission of retroviruses: human T-lymphotropic virus types I and II compared with human immunodeficiency virus type 1. Transfusion. 1994 Jun; 34(6):478-83.
Mosley JW, Nowicki MJ, Kasper CK, Donegan E, Aledort LM, Hilgartner MW, Operskalski EA. Hepatitis A virus transmission by blood products in the United States. Transfusion Safety Study Group. Vox Sang. 1994; 67 Suppl 1:24-8.
Busch MP, Lee TH, Donegan E, Pallavicini M. Use of an inbred mouse model system for studies of allogeneic transfusion-induced immunosuppression. Blood. 1993 Dec 1; 82(11):3509-11.
Hassett J, Gjerset GF, Mosley JW, Fletcher MA, Donegan E, Parker JW, Counts RB, Aledort LM, Lee H, Pike MC. Effect on lymphocyte subsets of clotting factor therapy in human immunodeficiency virus-1-negative congenital clotting disorders. The Transfusion Safety Study Group. Blood. 1993 Aug 15; 82(4):1351-7.
Lake JR, Wright T, Ferrell L, Donegan E, Roberts J, Ascher N. Hepatitis C and B in liver transplantation. Transplant Proc. 1993 Apr; 25(2):2006-9.
Rice HE, Hedrick MH, Flake AW, Donegan E, Harrison MR. Bacterial and fungal contamination of human fetal liver collected transvaginally for hematopoietic stem cell transplantation. Fetal Diagn Ther. 1993 Mar-Apr; 8(2):74-8.
Fletcher MA, Mosley JW, Hassett J, Gjerset GF, Kaplan J, Parker JW, Donegan E, Lusher JM, Lee H. Effect of age on human immunodeficiency virus type 1-induced changes in lymphocyte populations among persons with congenital clotting disorders. Transfusion Safety Study Group. Blood. 1992 Aug 1; 80(3):831-40.
Wright TL, Donegan E, Hsu HH, Ferrell L, Lake JR, Kim M, Combs C, Fennessy S, Roberts JP, Ascher NL. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology. 1992 Jul; 103(1):317-22.
Pepose JS, Buerger DG, Paul DA, Quinn TC, Darragh TM, Donegan E. New developments in serologic screening of corneal donors for HIV-1 and hepatitis B virus infections. Ophthalmology. 1992 Jun; 99(6):879-88.
Wright TL, Mamish D, Combs C, Kim M, Donegan E, Ferrell L, Lake J, Roberts J, Ascher NL. Hepatitis B virus and apparent fulminant non-A, non-B hepatitis. Lancet. 1992 Apr 18; 339(8799):952-5.
Donegan E, Pell P, Lee H, Shaw GM, Mosley JW. Transmission of human T-lymphotropic virus type I by blood components from a donor lacking anti-p24: a case report. The Transfusion Safety Study Group. Transfusion. 1992 Jan; 32(1):68-71.
Lee TH, el-Amad Z, Reis M, Adams M, Donegan EA, O'Brien TR, Moss AR, Busch MP. Absence of HIV-1 DNA in high-risk seronegative individuals using high-input polymerase chain reaction. AIDS. 1991 Oct; 5(10):1201-7.
Wright TL, Hsu H, Donegan E, Feinstone S, Greenberg H, Read A, Ascher NL, Roberts JP, Lake JR. Hepatitis C virus not found in fulminant non-A, non-B hepatitis. Ann Intern Med. 1991 Jul 15; 115(2):111-2.
Read AE, Donegan E, Lake J, Ferrell L, Galbraith C, Kuramoto IK, Zeldis JB, Ascher NL, Roberts J, Wright TL. Hepatitis C in patients undergoing liver transplantation. Ann Intern Med. 1991 Feb 15; 114(4):282-4.
Cregan P, Donegan E, Gotelli G. Hemolytic transfusion reaction following transfusion of frozen and washed autologous red cells. Transfusion. 1991 Feb; 31(2):172-5.
Read AE, Donegan E, Lake J, Ferrell L, Galbraith C, Kuramoto IK, Zeldis JB, Ascher NL, Roberts J, Wright TL. Hepatitis C in liver transplant recipients. Transplant Proc. 1991 Feb; 23(1 Pt 2):1504-5.
Fletcher MA, Gjerset GF, Hassett J, Donegan E, Parker JW, Mosley JW. Lymphocyte immunophenotypes among anti-HTLV-I/II-positive blood donors and recipients. The Transfusion Safety Study Group. J Acquir Immune Defic Syndr. 1991; 4(6):628-32.
Donegan E, Stuart M, Niland JC, Sacks HS, Azen SP, Dietrich SL, Faucett C, Fletcher MA, Kleinman SH, Operskalski EA. Infection with human immunodeficiency virus type 1 (HIV-1) among recipients of antibody-positive blood donations. Ann Intern Med. 1990 Nov 15; 113(10):733-9.
Donegan E, Lenes BA, Tomasulo PA, Mosley JW, Mosely JW. Transmission of HIV-1 by component type and duration of shelf storage before transfusion. Transfusion. 1990 Nov-Dec; 30(9):851-2.
Donegan E, Busch MP, Galleshaw JA, Shaw GM, Mosley JW. Transfusion of blood components from a donor with human T-lymphotropic virus type II (HTLV-II) infection. The Transfusion Safety Study Group. Ann Intern Med. 1990 Oct 1; 113(7):555-6.
Busch MP, Donegan E, Stuart M, Mosley JW. Donor HIV-1 p24 antigenaemia and course of infection in recipients Transfusion Safety Study Group. Lancet. 1990 Jun 2; 335(8701):1342.
Miller K, Donegan E, Curran P, Shelley TJ. Effects of counselling on knowledge about HIV-1 among transfusion recipients and their partners. Transfusion Safety Study Group. AIDS Care. 1990; 2(2):155-62.
Operskalski EA, Schiff ER, Kleinman SH, Busch M, Taylor PE, Parks WP, Lee H, Tomasulo PA, Donegan E, Stuart M. Epidemiologic background of blood donors with antibody to human T-cell lymphotropic virus. Transfusion Safety Study Group. Transfusion. 1989 Oct; 29(8):746-8.
Hjelle B, Donegan E, Cruz J, Stites D. Antibody to c antigen consequent to renal transplantation. Transfusion. 1988 Sep-Oct; 28(5):496-8.
Donegan E, Johnson D, Remedios V, Cohen S. Mass notification of transfusion recipients at risk for HIV infection. JAMA. 1988 Aug 19; 260(7):922-3.
Hales M, Bottles K, Miller T, Donegan E, Ljung BM. Diagnosis of Kaposi's sarcoma by fine-needle aspiration biopsy. Am J Clin Pathol. 1987 Jul; 88(1):20-5.
Bottles K, Miller TR, Jeffrey RB, Cohen MB, Stoloff A, Hales M, Ljung BM, Donegan E. Aspiration cytology characterization of inflammatory masses. West J Med. 1986 Jun; 144(6):695-9.
Swenson CE, Donegan E, Schachter J. Chlamydia trachomatis-induced salpingitis in mice. J Infect Dis. 1983 Dec; 148(6):1101-7.
Donegan EA, Deal MM, Melanephy MC, Cordes LG, Moss CW, Pons VG, Brooks GF. Primary isolation of a new strain of the TATLOCK/Pittsburgh pneumonia agent (Legionella micdadei). West J Med. 1981 May; 134(5):384-9.
Draper DL, Donegan EA, James JF, Sweet RL, Brooks GF. Scanning electron microscopy of attachment of Neisseria gonorrhoeae colony phenotypes to surfaces of human genital epithelia. Am J Obstet Gynecol. 1980 Dec 1; 138(7 Pt 1):818-26.
Draper DL, Donegan EA, James JF, Sweet RL, Brooks GF. In vitro modeling of acute salpingitis caused by Neisseria gonorrhoeae. Am J Obstet Gynecol. 1980 Dec 1; 138(7 Pt 2):996-1002.
Sweet R, Banks J, Sung M, Donegan E, Schachter J. Experimental chlamydial salpingitis in the guinea pig. Am J Obstet Gynecol. 1980 Dec 1; 138(7 Pt 2):952-6.
Donegan EA, Riggs HG. In vitro incorporation of serine into the staphylococcal cell wall. Infect Immun. 1974 Jul; 10(1):264-9.
DONEGAN EA. Ocular findings in tropical typhus (Tsutsugamushi or Japanese river fever). Br J Ophthalmol. 1946 Jan; 30:11-9.
Donegan EA. OCULAR FINDINGS IN TROPICAL TYPHUS(Tsutsugamushi or Japanese River Fever). Br J Ophthalmol. 1946 Jan; 30(1):11-9.